General Information of DTT (ID: TTIEMFN)

DTT Name TYRO3 tyrosine kinase receptor (TYRO3) DTT Info
Gene Name TYRO3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
RXDX-106 DM6NVTR Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
------------------------------------------------------------------------------------
7 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BDBM50444058 DM9GLQB N. A. N. A. Patented [2]
BDBM50444059 DMS0EMU N. A. N. A. Patented [2]
BDBM50444062 DMR2UGC N. A. N. A. Patented [2]
KRDULPYOVRWKMA-UHFFFAOYSA-N DMRY7KV N. A. N. A. Patented [3]
US10053465, 12 DMPM8VB N. A. N. A. Patented [4]
US10053465, 5 DMV7BF2 N. A. N. A. Patented [4]
US10053465, 8 DM42XWO N. A. N. A. Patented [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Patented Agent(s)
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
LDC1267 DMH7R6L Discovery agent N.A. Investigative [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 National Cancer Institute Drug Dictionary (drug name RXDX106).
2 Therapeutic uses of selected pyrimidine compounds with anti-Mer tyrosine kinase activity. US9649309.
3 Pyrrolopyrimidine derivatives as TAM inhibitors. US10053465.
4 Fused bicyclic 1,2,4-triazine compounds as TAM inhibitors. US9708333.
5 The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Nature. 2014 Mar 27;507(7493):508-12.